Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-၀.၂၁%
၁,၀၉၁.၅၁
-၂.၃၀
-၀.၂၁%
၁,၀၉၃.၈၁၁,၀၉၆.၅၂၁,၁၀၀.၂၂၁,၀၉၁.၅၁
SIXC
Communications
SIXC
Communications
SIXC
+၀.၂၂%
၆၁၀.၁၁
+၁.၃၄
+၀.၂၂%
၆၀၈.၇၇၆၀၈.၇၇၆၁၂.၉၇၆၀၈.၇၇
SIXE
Energy
SIXE
Energy
SIXE
-၁.၃၄%
၁,၂၃၇.၉၈
-၁၆.၈၃
-၁.၃၄%
၁,၂၅၄.၈၁၁,၂၅၃.၀၁၁,၂၅၃.၈၇၁,၂၂၆.၃၃
SIXI
Industrials
SIXI
Industrials
SIXI
-၀.၉၃%
၁,၇၄၄.၇၁
-၁၆.၄၀
-၀.၉၃%
၁,၇၆၁.၁၁၁,၇၆၄.၂၇၁,၇၆၆.၈၈၁,၇၄၄.၇၁
SIXM
Financials
SIXM
Financials
SIXM
-၀.၃၇%
၆၄၀.၁၈
-၂.၄၀
-၀.၃၇%
၆၄၂.၅၈၆၄၄.၈၇၆၄၈.၄၈၆၄၀.၁၈
SIXR
Staples
SIXR
Staples
SIXR
-၀.၁၈%
၈၄၉.၅၈
-၁.၅၅
-၀.၁၈%
၈၅၁.၁၃၈၅၅.၆၆၈၅၈.၇၅၈၄၅.၅၆
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-၀.၂၃%
၂၁၇.၄၈
-၀.၅၀
-၀.၂၃%
၂၁၇.၉၈၂၁၇.၉၈၂၁၈.၆၅၂၁၆.၈၈
SIXT
Technology
SIXT
Technology
SIXT
+၁.၅၂%
၃,၂၆၀.၆၉
+၄၈.၈၆
+၁.၅၂%
၃,၂၁၁.၈၃၃,၂၂၇.၂၁၃,၂၆၈.၃၈၃,၂၂၆.၅၅
SIXU
Utilities
SIXU
Utilities
SIXU
-၀.၆၉%
၉၄၂.၄၅
-၆.၅၃
-၀.၆၉%
၉၄၈.၉၈၉၄၈.၅၈၉၅၇.၈၃၉၄၁.၉၇
SIXV
Health care
SIXV
Health care
SIXV
-၀.၅၂%
၁,၄၆၆.၈၀
-၇.၇၂
-၀.၅၂%
၁,၄၇၄.၅၂၁,၄၇၉.၀၃၁,၄၈၁.၀၄၁,၄၆၆.၈၀
SIXY
Discretionary
SIXY
Discretionary
SIXY
+၀.၂၂%
၂,၃၉၇.၅၀
+၅.၃၈
+၀.၂၂%
၂,၃၉၂.၁၂၂,၃၉၆.၉၅၂,၄၂၁.၂၂၂,၃၈၂.၃၂
INCY:NASDAQ
Incyte Corp
၉၆.၉၁ US$
+၁.၇၂%
(+၁.၆၄) 1D
၉၇.၄၀ US$
+၀.၅၁% (+၀.၄၉)
After hours
Closed: မေ ၁, GMT-၄ ၁၆:၀၀:၀၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INCY...
Open
၉၅.၂၆ US$
High
၉၇.၀၅ US$
Low
၉၄.၈၂ US$
Mkt. cap
ဋေ ၁.၉၄ ထ
Avg. vol.
၁.၅၃ သန်း
Volume
၁.၂၀ သန်း
P/E ratio
၁၃.၇၀
52-wk high
၁၁၂.၂၉ US$
52-wk low
၅၇.၂၉ US$
EPS
၇.၀၇ US$
Beta
၀.၈၅
Shares outstanding
၁၉.၉၈ ကုဋေ
No. of employees
၃ ထောင်
News stories
From sources across the web
Stock Traders Daily
Stock Traders Daily
·
ပြီးခဲ့သည့် ၁၇ နာရီ
How Incyte Corporation (INCY) Affects Rotational Strategy Timing
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၂၁ နာရီ
Incyte (INCY) Positioned to Offset Patent Cliff Risks, Analysts Reaffirm Stock Ratings
Simply Wall Street
Simply Wall Street
·
ပြီးခဲ့သည့် ၁ ရက်
Is It Too Late To Consider Incyte (INCY) After A 55% One Year Rally?
Investing.com Nigeria
Investing.com Nigeria
·
ပြီးခဲ့သည့် ၁ ရက်
FDA approves Incyte’s once-daily Jakafi XR formulation By Investing.com
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia. Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEOHervé Hoppenot
Employees၂.၈၄ ထောင်
Founded၂၀၀၂
HeadquartersWilmington, ဒယ်လာဝဲပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websiteincyte.com
Last report
၂၀၂၆ ဧ ၂၈
Fiscal Period
Q1 2026
Normalized EPS / Estimate
၁.၈၁/ (၁.၃၄ est.)USD
+၃၅.၁၂%beat
Revenue / Estimate
၁၂၇.၂၇ ဋေ/ (၁၂၁.၁၃ ဋေ est.)USD
+၅.၀၇%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
Revenue
၁၂၁.၅၅ ဋေ
၁၃၆.၆၀ ဋေ
၁၅၀.၆၈ ဋေ
၁၂၇.၂၇ ဋေ
Cost of goods sold
၅၇.၃၇ ကုဋေ
၆၀.၅၆ ကုဋေ
၇၃.၂၅ ကုဋေ
၆၂.၀၄ ကုဋေ
Cost of revenue
၅၇.၃၇ ကုဋေ
၆၀.၅၆ ကုဋေ
၇၃.၂၅ ကုဋေ
၆၂.၀၄ ကုဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃၃.၀၃ ကုဋေ
၃၂.၈၃ ကုဋေ
၃၈.၉၀ ကုဋေ
၃၂.၇၁ ကုဋေ
Operating expense
၃၃.၀၃ ကုဋေ
၃၂.၈၃ ကုဋေ
၃၈.၉၀ ကုဋေ
၃၂.၇၁ ကုဋေ
Total operating expenses
၉၀.၃၉ ကုဋေ
၉၃.၃၉ ကုဋေ
၁၁၂.၁၅ ဋေ
၉၄.၇၅ ကုဋေ
Operating income
၃၁.၁၆ ကုဋေ
၄၃.၂၁ ကုဋေ
၃၈.၅၃ ကုဋေ
၃၂.၅၂ ကုဋေ
Other non operating income
၆.၅၄ သန်း
၃.၂၅ သန်း
၄.၂၂ သန်း
၁.၇၅ သန်း
EBT including unusual items
၅၅.၈၀ ကုဋေ
၄၈.၂၃ ကုဋေ
၃၈.၉၉ ကုဋေ
၃၄.၃၆ ကုဋေ
EBT excluding unusual items
၃၄.၂၇ ကုဋေ
၄၆.၁၅ ကုဋေ
၄၁.၉၇ ကုဋေ
၃၆.၀၁ ကုဋေ
Income tax expense
၁၅.၃၀ ကုဋေ
၅.၈၁ ကုဋေ
၉.၀၇ ကုဋေ
၄.၀၃ ကုဋေ
Effective tax rate
၂၇.၄၂%
၁၂.၀၅%
၂၃.၂၅%
၁၁.၇၂%
Other operating expenses
-
-
-
-
Net income
၄၀.၅၀ ကုဋေ
၄၂.၄၂ ကုဋေ
၂၉.၉၃ ကုဋေ
၃၀.၃၃ ကုဋေ
Net profit margin
၃၃.၃၂%
၃၁.၀၅%
၁၉.၈၆%
၂၃.၈၃%
Earnings per share
၁.၅၇
၂.၂၆
၁.၈၀
၁.၈၁
Interest and investment income
၂.၅၁ ကုဋေ
၂.၆၈ ကုဋေ
၃.၀၈ ကုဋေ
၃.၃၇ ကုဋေ
Interest expense
-၅.၉၄ သိန်း
-၅.၉၂ သိန်း
-၅.၈၂ သိန်း
-၅.၆၉ သိန်း
Net interest expenses
၂.၄၅ ကုဋေ
၂.၆၂ ကုဋေ
၃.၀၂ ကုဋေ
၃.၃၁ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၃၃.၄၅ ကုဋေ
၄၅.၆၁ ကုဋေ
၄၀.၉၃ ကုဋေ
၃၄.၉၀ ကုဋေ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more